Von Willebrand factor and soluble E-selectin in hyperlipidaemia: Relationship to lipids and vascular disease
Open Access
- 1 May 1997
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 55 (1) , 15-23
- https://doi.org/10.1002/(sici)1096-8652(199705)55:1<15::aid-ajh3>3.0.co;2-6
Abstract
Our objective was to determine whether endothelial cell products von Willebrand factor and soluble E‐selectin are related to serum lipids, lipoprotein (a), and vascular disease in patients with hyperlipidaemia. In order to achieve our aim, blood samples were obtained for four experiments from 1) 160 patients (49 with symptomatic vascular disease) with hypercholesterolaemia and an equal number of age and sex matched controls; 2) 31 patients who were studied serially before and after successful resolution of their hypercholesterolaemia; 3) 15 patients with hypertriglyceridaemia; and 4) 20 controls, half of whom consumed a lipid‐rich breakfast. von Willebrand factor and soluble E‐selectin were measured by enzyme linked immunosorbent assay (ELISA) using commercial reagents. In experiment (1) von Willebrand factor was increased in the patients with hypercholesterolaemia (P=0.0077) and was higher still in patients with vascular disease (PPP=0.002). Experiment (3) demonstrated that von Willebrand factor was not increased in patients with hypertriglyceridaemia (median 8.9 mmol/L), and in experiment (4) a lipid‐rich breakfast taken by fasted, healthy controls produced an increase in serum triglycerides (P<0.01) but did not influence von Willebrand factor over an 8 hour period. We conclude that von Willebrand factor, but not soluble E‐selectin, is raised in hypercholesterolaemia and therefore may be a potential indicator of endothelial cell physiology in subjects with, or at risk of, atherosclerotic vascular disease. Am. J. Hematol. 55:15‐23, 1997.Keywords
This publication has 46 references indexed in Scilit:
- von Willebrand factor and soluble E-selectin in hypertensionCoronary Artery Disease, 1996
- Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular diseaseAtherosclerosis, 1995
- Circulating adhesion molecules in diseaseImmunology Today, 1993
- MARKERS OF ENDOTHELIAL PERTURBATION AND DAMAGERheumatology, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Atherosclerotic risk factors — are there ten, or is there only one?Atherosclerosis, 1992
- Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Lipoprotein (a). Heterogeneity and biological relevance.Journal of Clinical Investigation, 1990
- Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1990
- Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect.BMJ, 1985